Global Immuno-Oncology Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024)
Scope of the Report
The report titled “Global Immuno-Oncology Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024)”, provides an in-depth analysis of the global immuno-oncology market by value and by region. The report provides a detailed analysis of the immuno-oncology assays market by value, by region, by application, etc. The report also provides a regional analysis of the immuno-oncology market, including the following regions: North America and Rest of World. Also detailed regional analysis of immuno-oncology assays market, including regions: North America, Europe and APAC.
The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global immuno-oncology market has also been forecasted for the period 2020-2024, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
The global immuno-oncology market is dominated with few major market players operating worldwide. Further, key players of the immuno-oncology market with focus on assays are Merck and Co., Pfizer Inc., Amgen and Roche Holding AG are also profiled with their financial information and respective business strategies.
Region Coverage
The global immuno-oncology market has increased at a significant growth during the year 2019 and projections are made that the market would rise in the next four years at a significant CAGR i.e. 2020-2024 tremendously. The immuno-oncology market is expected to increase due to the rising number of cancer cases, unhealthy changes in dietary patterns, higher investments in the research and development, growing approvals of medicines for the treatment of various types of cancer, etc. Yet the market faces some challenges such as development of pre-clinical models, side-effects post immunotherapy and the declining composite success rate of oncology clinical trials, etc.
The global immuno-oncology market also follows some market trends which includes the CAR-NKs, CAR-Ms, Next-Gen CARs, accelerating immuno-oncology research, evolution of biosimilars in oncology, purchasing and reimbursement actions globally, etc.
The report titled “Global Immuno-Oncology Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024)”, provides an in-depth analysis of the global immuno-oncology market by value and by region. The report provides a detailed analysis of the immuno-oncology assays market by value, by region, by application, etc. The report also provides a regional analysis of the immuno-oncology market, including the following regions: North America and Rest of World. Also detailed regional analysis of immuno-oncology assays market, including regions: North America, Europe and APAC.
The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global immuno-oncology market has also been forecasted for the period 2020-2024, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
The global immuno-oncology market is dominated with few major market players operating worldwide. Further, key players of the immuno-oncology market with focus on assays are Merck and Co., Pfizer Inc., Amgen and Roche Holding AG are also profiled with their financial information and respective business strategies.
Region Coverage
- North America
- Asia Pacific
- Europe
- ROW
- Merck and Co.
- Pfizer Inc.
- Amgen
- Roche Holding AG
The global immuno-oncology market has increased at a significant growth during the year 2019 and projections are made that the market would rise in the next four years at a significant CAGR i.e. 2020-2024 tremendously. The immuno-oncology market is expected to increase due to the rising number of cancer cases, unhealthy changes in dietary patterns, higher investments in the research and development, growing approvals of medicines for the treatment of various types of cancer, etc. Yet the market faces some challenges such as development of pre-clinical models, side-effects post immunotherapy and the declining composite success rate of oncology clinical trials, etc.
The global immuno-oncology market also follows some market trends which includes the CAR-NKs, CAR-Ms, Next-Gen CARs, accelerating immuno-oncology research, evolution of biosimilars in oncology, purchasing and reimbursement actions globally, etc.
1. EXECUTIVE SUMMARY
2. INTRODUCTION
2.1 Immuno-Oncology: An Overview
2.1.1 Introduction
2.1.2 Cancer-Targeting Immunotherapies
2.2 Immuno-Oncology Segmentation
2.2.1 Immuno-Oncology Segmentation by Application
2.3 Working of Immuno-Oncology
2.4 Benefits and Risks of Immuno-Oncology
2.4.1 Benefits of Immuno-Oncology
2.4.2 Risks of Immuno-Oncology
2.5 Immuno-Oncology Assays: An Overview
2.5.1 Introduction
2.5.2 Immuno-Oncology Assays Types
2.6 Immuno-Oncology Assays Segmentation
2.6.1 Immuno-Oncology Assays Segmentation by Technology
3. GLOBAL MARKET ANALYSIS
3.1 Global Immuno-Oncology Market Analysis
3.1.1 Global Immuno-Oncology Market by Value
3.1.2 Global Immuno-Oncology Market by Region (North America and ROW)
3.2 Global Immuno-Oncology Assays Market Analysis
3.2.1 Global Immuno-Oncology Assays Market by Value
3.2.2 Global Immuno-Oncology Assays Market by Region (North America, Europe, APAC and ROW)
3.2.3 Global Immuno-Oncology Assays Market by Application (Clinical Diagnostic and Research)
4. REGIONAL MARKET ANALYSIS
4.1 North America Immuno-Oncology Market Analysis
4.1.1 North America Immuno-Oncology Market by Value
4.2 ROW Immuno-Oncology Market Analysis
4.2.1 ROW Immuno-Oncology Market by Value
4.3 North America Immuno-Oncology Assays Market Analysis
4.3.1 North America Immuno-Oncology Assays Market by Value
4.4 Europe Immuno-Oncology Assays Market Analysis
4.4.1 Europe Immuno-Oncology Assays Market by Value
4.5 APAC Immuno-Oncology Assays Market Analysis
4.5.1 APAC Immuno-Oncology Assays Market by Value
5. COVID-19
5.1 Impact of Covid-19
5.2 Response of Industry to Covid-19
5.3 Global Number of COVID-19 Active Cases
5.4 Variation in Organic Traffic
6. MARKET DYNAMICS
6.1 Growth Drivers
6.1.1 Increase in Oncology Spending
6.1.2 Approval of New Active Substance (NAS) in Oncology
6.1.3 Rising Cancer Cases
6.1.4 Unhealthy Changes in Dietary Patterns
6.1.5 Excessive Use of Tobacco
6.1.6 Rise in Alcohol Consumption
6.2 Challenges
6.2.1 Development of Pre-clinical Models
6.2.2 Lower Composite Success Rate of Oncology Clinical Trials
6.2.3 Side-Effects after Immunotherapy
6.3 Market Trends
6.3.1 CAR-NKs, CAR-Ms, Next-Gen CARs
6.3.2 Evolution of Biosimilars in Oncology
6.3.3 Accelerating Immuno-Oncology Research
6.3.4 Purchasing and Reimbursement Actions
7. COMPETITIVE LANDSCAPE
7.1 Global Immuno-Oncology Market: A Financial Comparison
7.2 Global Immuno-Oncology Market Players by Research and Development
8. COMPANY PROFILES
8.1 Merck and Co.
8.1.1 Business Overview
8.1.2 Financial Overview
8.1.3 Business Strategy
8.2 Pfizer Inc.
8.2.1 Business Overview
8.2.2 Financial Overview
8.2.3 Business Strategy
8.3 Amgen
8.3.1 Business Overview
8.3.2 Financial Overview
8.3.3 Business Strategy
8.4 Roche Holding AG
8.4.1 Business Overview
8.4.2 Financial Overview
8.4.3 Business Strategy
2. INTRODUCTION
2.1 Immuno-Oncology: An Overview
2.1.1 Introduction
2.1.2 Cancer-Targeting Immunotherapies
2.2 Immuno-Oncology Segmentation
2.2.1 Immuno-Oncology Segmentation by Application
2.3 Working of Immuno-Oncology
2.4 Benefits and Risks of Immuno-Oncology
2.4.1 Benefits of Immuno-Oncology
2.4.2 Risks of Immuno-Oncology
2.5 Immuno-Oncology Assays: An Overview
2.5.1 Introduction
2.5.2 Immuno-Oncology Assays Types
2.6 Immuno-Oncology Assays Segmentation
2.6.1 Immuno-Oncology Assays Segmentation by Technology
3. GLOBAL MARKET ANALYSIS
3.1 Global Immuno-Oncology Market Analysis
3.1.1 Global Immuno-Oncology Market by Value
3.1.2 Global Immuno-Oncology Market by Region (North America and ROW)
3.2 Global Immuno-Oncology Assays Market Analysis
3.2.1 Global Immuno-Oncology Assays Market by Value
3.2.2 Global Immuno-Oncology Assays Market by Region (North America, Europe, APAC and ROW)
3.2.3 Global Immuno-Oncology Assays Market by Application (Clinical Diagnostic and Research)
4. REGIONAL MARKET ANALYSIS
4.1 North America Immuno-Oncology Market Analysis
4.1.1 North America Immuno-Oncology Market by Value
4.2 ROW Immuno-Oncology Market Analysis
4.2.1 ROW Immuno-Oncology Market by Value
4.3 North America Immuno-Oncology Assays Market Analysis
4.3.1 North America Immuno-Oncology Assays Market by Value
4.4 Europe Immuno-Oncology Assays Market Analysis
4.4.1 Europe Immuno-Oncology Assays Market by Value
4.5 APAC Immuno-Oncology Assays Market Analysis
4.5.1 APAC Immuno-Oncology Assays Market by Value
5. COVID-19
5.1 Impact of Covid-19
5.2 Response of Industry to Covid-19
5.3 Global Number of COVID-19 Active Cases
5.4 Variation in Organic Traffic
6. MARKET DYNAMICS
6.1 Growth Drivers
6.1.1 Increase in Oncology Spending
6.1.2 Approval of New Active Substance (NAS) in Oncology
6.1.3 Rising Cancer Cases
6.1.4 Unhealthy Changes in Dietary Patterns
6.1.5 Excessive Use of Tobacco
6.1.6 Rise in Alcohol Consumption
6.2 Challenges
6.2.1 Development of Pre-clinical Models
6.2.2 Lower Composite Success Rate of Oncology Clinical Trials
6.2.3 Side-Effects after Immunotherapy
6.3 Market Trends
6.3.1 CAR-NKs, CAR-Ms, Next-Gen CARs
6.3.2 Evolution of Biosimilars in Oncology
6.3.3 Accelerating Immuno-Oncology Research
6.3.4 Purchasing and Reimbursement Actions
7. COMPETITIVE LANDSCAPE
7.1 Global Immuno-Oncology Market: A Financial Comparison
7.2 Global Immuno-Oncology Market Players by Research and Development
8. COMPANY PROFILES
8.1 Merck and Co.
8.1.1 Business Overview
8.1.2 Financial Overview
8.1.3 Business Strategy
8.2 Pfizer Inc.
8.2.1 Business Overview
8.2.2 Financial Overview
8.2.3 Business Strategy
8.3 Amgen
8.3.1 Business Overview
8.3.2 Financial Overview
8.3.3 Business Strategy
8.4 Roche Holding AG
8.4.1 Business Overview
8.4.2 Financial Overview
8.4.3 Business Strategy
LIST OF FIGURES
Figure 1: Cancer-Targeting Immunotherapy Types
Figure 2: Immuno-Oncology Segmentation by Application
Figure 3: Organs Functions during Immunotherapy
Figure 4: Benefits of Immuno-Oncology
Figure 5: Risks of Immuno-Oncology
Figure 6: Cell-Based Immuno-Oncology Assays
Figure 7: Immuno-Oncology Assays Segmentation by Technology
Figure 8: Global Immuno-Oncology Market by Value; 2018-2019 (US$ Billion)
Figure 9: Global Immuno-Oncology Market by Value; 2020-2024 (US$ Billion)
Figure 10: Global Immuno-Oncology Market by Region; 2019 (Percentage, %)
Figure 11: Global Immuno-Oncology Assays Market by Value; 2018-2019 (US$ Billion)
Figure 12: Global Immuno-Oncology Assays Market by Value; 2020-2024 (US$ Billion)
Figure 13: Global Immuno-Oncology Assays Market by Region; 2019 (Percentage, %)
Figure 14: Global Immuno-Oncology Assays Market by Application; 2019 (Percentage, %)
Figure 15: North America Immuno-Oncology Market by Value; 2018-2019 (US$ Billion)
Figure 16: North America Immuno-Oncology Market by Value; 2020-2024 (US$ Billion)
Figure 17: ROW Immuno-Oncology Market by Value; 2018-2019 (US$ Billion)
Figure 18: ROW Immuno-Oncology Market by Value; 2020-2024 (US$ Billion)
Figure 19: North America Immuno-Oncology Assays Market by Value; 2018-2019 (US$ Billion)
Figure 20: North America Immuno-Oncology Assays Market by Value; 2020-2024 (US$ Billion)
Figure 21: Europe Immuno-Oncology Assays Market by Value; 2018-2019 (US$ Billion)
Figure 22: Europe Immuno-Oncology Assays Market by Value; 2020-2024 (US$ Billion)
Figure 23: APAC Immuno-Oncology Assays Market by Value; 2018-2019 (US$ Billion)
Figure 24: APAC Immuno-Oncology Assays Market by Value; 2020-2024 (US$ Billion)
Figure 25: Global Number of COVID-19 Active Cases, 2020 (Thousand)
Figure 26: Variation in Organic Traffic due to COVID-19 (2020)
Figure 27: Global Spending on Oncology; 2014-2023 (US$ Billion)
Figure 28: New Active Substance Approvals in Oncology; 2018
Figure 29: Global Cancer Cases; 2015-2035 (Million)
Figure 30: Global Packed Food Sales; 2015-2019 (US$ Trillion)
Figure 31: Global Cigarettes, Smoking Tobacco and Cigars Revenue; 2018-2023 (US$ Billion)
Figure 32: Global Alcoholic Beverages Market, 2018-2024 (US$ Trillion)
Figure 33: Composite Success Rate of Oncology Clinical Trials; 2010-2018 (Percentage, %)
Figure 34: Global Immuno-Oncology Market Players by Research and Development Expenses; 2018-2019 (US$ Billion)
Figure 35: Merck and Co. Segments Overview
Figure 36: Merck and Co. Sales; 2015-2019 (US$ Billion)
Figure 37: Merck and Co. Sales by Segments; 2019 (Percentage, %)
Figure 38: Merck and Co. Sales by Region; 2019 (Percentage, %)
Figure 39: Pfizer Inc. Revenue; 2015-2019 (US$ Billion)
Figure 40: Pfizer Inc. Revenue by Segments; 2019 (Percentage, %)
Figure 41: Pfizer Inc. Revenue by Region; 2019 (Percentage, %)
Figure 42: Amgen Total Revenue; 2015-2019 (US$ Billion)
Figure 43: Amgen Total Revenue by Products; 2019 (Percentage, %)
Figure 44: Amgen Total Revenue by Region; 2019 (Percentage, %)
Figure 45: Roche Holding AG Sales; 2015-2019 (US$ Billion)
Figure 46: Roche Holding AG Sales by Segments; 2019 (Percentage, %)
Figure 47: Roche Holding AG Sales by Region; 2019 (Percentage, %)
Table 1: Global Immuno-Oncology Market: A Financial Comparison; 2019 (US$ Billion)
Figure 1: Cancer-Targeting Immunotherapy Types
Figure 2: Immuno-Oncology Segmentation by Application
Figure 3: Organs Functions during Immunotherapy
Figure 4: Benefits of Immuno-Oncology
Figure 5: Risks of Immuno-Oncology
Figure 6: Cell-Based Immuno-Oncology Assays
Figure 7: Immuno-Oncology Assays Segmentation by Technology
Figure 8: Global Immuno-Oncology Market by Value; 2018-2019 (US$ Billion)
Figure 9: Global Immuno-Oncology Market by Value; 2020-2024 (US$ Billion)
Figure 10: Global Immuno-Oncology Market by Region; 2019 (Percentage, %)
Figure 11: Global Immuno-Oncology Assays Market by Value; 2018-2019 (US$ Billion)
Figure 12: Global Immuno-Oncology Assays Market by Value; 2020-2024 (US$ Billion)
Figure 13: Global Immuno-Oncology Assays Market by Region; 2019 (Percentage, %)
Figure 14: Global Immuno-Oncology Assays Market by Application; 2019 (Percentage, %)
Figure 15: North America Immuno-Oncology Market by Value; 2018-2019 (US$ Billion)
Figure 16: North America Immuno-Oncology Market by Value; 2020-2024 (US$ Billion)
Figure 17: ROW Immuno-Oncology Market by Value; 2018-2019 (US$ Billion)
Figure 18: ROW Immuno-Oncology Market by Value; 2020-2024 (US$ Billion)
Figure 19: North America Immuno-Oncology Assays Market by Value; 2018-2019 (US$ Billion)
Figure 20: North America Immuno-Oncology Assays Market by Value; 2020-2024 (US$ Billion)
Figure 21: Europe Immuno-Oncology Assays Market by Value; 2018-2019 (US$ Billion)
Figure 22: Europe Immuno-Oncology Assays Market by Value; 2020-2024 (US$ Billion)
Figure 23: APAC Immuno-Oncology Assays Market by Value; 2018-2019 (US$ Billion)
Figure 24: APAC Immuno-Oncology Assays Market by Value; 2020-2024 (US$ Billion)
Figure 25: Global Number of COVID-19 Active Cases, 2020 (Thousand)
Figure 26: Variation in Organic Traffic due to COVID-19 (2020)
Figure 27: Global Spending on Oncology; 2014-2023 (US$ Billion)
Figure 28: New Active Substance Approvals in Oncology; 2018
Figure 29: Global Cancer Cases; 2015-2035 (Million)
Figure 30: Global Packed Food Sales; 2015-2019 (US$ Trillion)
Figure 31: Global Cigarettes, Smoking Tobacco and Cigars Revenue; 2018-2023 (US$ Billion)
Figure 32: Global Alcoholic Beverages Market, 2018-2024 (US$ Trillion)
Figure 33: Composite Success Rate of Oncology Clinical Trials; 2010-2018 (Percentage, %)
Figure 34: Global Immuno-Oncology Market Players by Research and Development Expenses; 2018-2019 (US$ Billion)
Figure 35: Merck and Co. Segments Overview
Figure 36: Merck and Co. Sales; 2015-2019 (US$ Billion)
Figure 37: Merck and Co. Sales by Segments; 2019 (Percentage, %)
Figure 38: Merck and Co. Sales by Region; 2019 (Percentage, %)
Figure 39: Pfizer Inc. Revenue; 2015-2019 (US$ Billion)
Figure 40: Pfizer Inc. Revenue by Segments; 2019 (Percentage, %)
Figure 41: Pfizer Inc. Revenue by Region; 2019 (Percentage, %)
Figure 42: Amgen Total Revenue; 2015-2019 (US$ Billion)
Figure 43: Amgen Total Revenue by Products; 2019 (Percentage, %)
Figure 44: Amgen Total Revenue by Region; 2019 (Percentage, %)
Figure 45: Roche Holding AG Sales; 2015-2019 (US$ Billion)
Figure 46: Roche Holding AG Sales by Segments; 2019 (Percentage, %)
Figure 47: Roche Holding AG Sales by Region; 2019 (Percentage, %)
Table 1: Global Immuno-Oncology Market: A Financial Comparison; 2019 (US$ Billion)
